[2] [2] Dennis ED,Dai F,Rakesh KJ,et al.Photodynamic them-py for cancer[J].Nature Rev,2003,3:380-387.

[4] [4] Fotinos N,Campo MA,Popewycz F,et al.5-ALA deriva-tires in photomedicine:characteristics,application and per-spectives[J].Photochem Photobiol,2006,82:994-1015.

[5] [5] Vancher L,Jichlinski P,Lange N,et al.Hexyl-aminole-vulinate-mediated photodynamic thempy:how to spare nor-mal urothehum.An in vitro approach[J].Lasers Surg Med,2007,39:67-75.

[6] [6] Stavropoulos NE,Kim A,Nseyo UU.et al.Hypericum perforatum L.extract novel photosensitizer against human bladder cancer cells[J].J Photochem Photobiol B,2006,84:64-69.

[7] [7] Hendrickx N,Dewaele M,Buytaert E,et al.Targeted in-hibition of p38alpha MAPK suppresses tumor associated en-dothelial cell migration in response to hypericin.based pho-todynamic therapy[J].Biochem Biophys Res Commun,2005,337:928-395.

[10] [10] Riedl CR,Danihchendo D,Koenig F,et al.Fluores-cence endoscopy with 5-aminolevulinic acid reduces the early recurrence rate in bladder cancer[J].J Urol,200l,165:1121-1123.

[11] [11] Pogue BW,Braun RD.Photodynamic therapy with verte-porfin in the radiation-induced fibrosarcoma-1 tumor cau-ses enhanced radiation sensitivity[J].Cancer Res,2003,63:1025-1033.

[12] [12] Kamuhabwa AR,Huygens A,Roskams T,et al.Enhan-cing the photodynamic effect of hypericin in human blad-der transitional cell carcinoma sphemids by the use of the oxygen carrier,perfluorodeealin[J].Int J Oncol,2006,28:775-780.

[13] [13] Iangmack K,Mehta R,Twyman P,et al.Topical photo-dynamic therapy at low fluence rates-theory and practice[J].J Photochem Photobiol B,2001,60:37-43.

[14] [14] Shackley DC,Briggs C,Gilhooley A,et al.Photodynam-ic therapy for superficial bladder cancer under local an-aesthetic[J].BJU Int,2002,89:656-670.

[15] [15] Van SH,Beck JF,Veflaan CW.et al.Comparison of normal piglet bladder damage after PDT with oral or intra-vesieal administration of ALA[J].Lasers Med Sci,2002,17:238-245.

[16] [16] Wahlfors J,Talja M,Kosma VM,et al.The effect of photodynamic therapy on rat urinary bladder with ortho-topic urothelial carcinoma[J].BJU Int,2003,92:125-130.

[17] [17] Manyak MJ,Ogan K.Photodynamlc therapy for refractory superficial bladder cancer:long term clinical outcomes of single treatment using intravesical diffusion medium[J].J Endourol,2003,17:633-639.

[18] [18] Turchiello RF,Vena FC,Maillard P,et al.Cubic phase gel as a drug delivery system for topical application of 5-ALA,its ester derivatives and m-THPC in photodynamic therapy(PDT)[J].J Photochem Photobiol B:Biology,2003,70:1-6.

[19] [19] Miron K,Miraslaw K,Asta J,et al.Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions[J].J Photochem Photobiol B:Biology,2007,87:67-72.

[20] [20] Andreasp PB,Hannes S,Arnulf S,et al.Photodynamic therapy with intravesical instillation of 5-ALA for patients with recurrent superficial bladder cancer:a singer center study[J].Urology,2003,61:338-341.

[21] [21] McClellan M,Walther MD.The role of photedynamic therapy in the treatment of recurrent superficial bladder cancer[J].Urol Clin North Am,2000,27:162-170.

[22] [22] Nseyo UO,Shumaker B,Klein E,et al.Photodynamic therapy using porfimer sodium as an alternative to cystec-tomy in patients with refractory transitional cell carcinoma in situ of the bladder[J].J Urol,1998,160:39-44.

[23] [23] Schaffer M,Schaffer PM.Application of Photofrin as a specific radiosensitizer agent in patients with bladder cancer-a report of two patients[J].Photochem Photobiol Sei,2002,1:686-689.

[24] [24] Christian L,Ruth K,Guenther B,et al.Combined che-motherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(Ⅱ)conju-gates[J].Cancer Lett,2004,203:171-180.

[25] [25] French AJ,Datta SN,Allman B,et al.Investigation of sequential mitomycin C and photodynamic therapy in a mi-tomycin-resistant bladder cancer cell-line model[J].BJU Int,2004,93:156-161.